Medicines affordability in the US

Some people with diabetes in the U.S. are increasingly finding it hard to pay for their healthcare, especially those uninsured and in high-deductible healthcare plans. This is not acceptable.

In line with our social responsibility as a company, we have several offerings today that may help people with diabetes who are struggling to afford their insulin, including:

  • For almost two decades, our human insulin has been available at Walmart for about $25/vial.?Recently our human insulin also began to be sold at other national pharmacy chains. About 500,000 Americans are using our human insulin through these partnerships.
  • Co-pay cards to help defray the costs of those who are experiencing high out-of-pocket costs that are driven by list price.
  • A patient assistance programme that, in 2018, provided free insulin to nearly 50,000 people with diabetes who didn’t have health insurance.?Through the programme, an individual with an annual income up to 49,960 US dollars, and a family of four with an annual income up to 103,000 US dollars, may qualify for free Novo Nordisk medicines which includes all Novo Nordisk insulin medications.

Despite these efforts, we continue to hear that people with diabetes need more. The complexity of the US healthcare system means that arriving at solutions that ensure affordable access to medicines for all is not straightforward. However, we believe that with a coordinated effort across all parties in the system, sustainable solutions can be achieved.

We want to be part of a solution and we are actively working with all parties in the US healthcare system to find ways that reduce the burden on patients both in the short-term and for longer-term reform.

Via the links below, you can read more about the steps we have taken towards affordable medicines for people living in the United States.


Our collaborations towards affordable medicines for americans

Our collaborations towards affordable medicines for Americans

See how we are working with third parties to provide affordable medicines in the US